Allele specific antibody response against the polymorphic system of HLA is the allogeneic response marker determining the immunological risk for graft acceptance before and after organ transplantation and therefore routinely studied during the patient’s workup. Experimentally, bead bound antigen- antibody reactions are detected using a special multicolor flow cytometer (Luminex). Routinely for each sample, antibody responses against 96 different HLA antigen groups are measured simultaneously and a 96-dimensional immune response vector is created. Under a common experimental protocol, using unsupervised clustering algorithms, we analyzed these immune intensity vectors of anti HLA class II responses from a dataset of 1,748 patients before or ...
TRANSPLANT candidates are generally consideredhighly alloimmunized if their serum panel-reactive ant...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Allele specific antibody response against the polymorphic system of HLA is the allogeneic response m...
Detection of alloreactive anti-HLA antibodies is a frequent and mandatory test before and after orga...
Current pre-transplantation routine matching involves serum anti-HLA antibodies quantification but c...
International audienceINTRODUCTION: HLA antigens are highly polymorphic and their immunogenicity is ...
Background. In highly sensitized patients (HSP) awaiting renal transplantation, accurate delineation...
Human leukocyte antigen (HLA) mismatches between donors and recipients may lead to alloreactivity af...
Both donor-specific anti-human leukocyte antigen (HLA) antibodies and cytotoxic T lymphocytes are im...
Background HLA antibody testing is essential for successful solid-organ allocation, patient monitori...
Background. HLA-specific antibodies detected by solid phase assays are increasingly used to define u...
We have assessed whether HLA immunogenicity as defined by differences in donor-recipient HLA amino-a...
Background. Human leukocyte antigen (HLA) matching strategies for kidney transplantation assign equa...
Production of de novo DSA (dnDSA) is associated with an increased risk of antibody mediated rejectio...
TRANSPLANT candidates are generally consideredhighly alloimmunized if their serum panel-reactive ant...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Allele specific antibody response against the polymorphic system of HLA is the allogeneic response m...
Detection of alloreactive anti-HLA antibodies is a frequent and mandatory test before and after orga...
Current pre-transplantation routine matching involves serum anti-HLA antibodies quantification but c...
International audienceINTRODUCTION: HLA antigens are highly polymorphic and their immunogenicity is ...
Background. In highly sensitized patients (HSP) awaiting renal transplantation, accurate delineation...
Human leukocyte antigen (HLA) mismatches between donors and recipients may lead to alloreactivity af...
Both donor-specific anti-human leukocyte antigen (HLA) antibodies and cytotoxic T lymphocytes are im...
Background HLA antibody testing is essential for successful solid-organ allocation, patient monitori...
Background. HLA-specific antibodies detected by solid phase assays are increasingly used to define u...
We have assessed whether HLA immunogenicity as defined by differences in donor-recipient HLA amino-a...
Background. Human leukocyte antigen (HLA) matching strategies for kidney transplantation assign equa...
Production of de novo DSA (dnDSA) is associated with an increased risk of antibody mediated rejectio...
TRANSPLANT candidates are generally consideredhighly alloimmunized if their serum panel-reactive ant...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...
Alloreactivity compromising clinical outcomes in stem cell transplantation is observed despite HLA m...